急性心肌梗死介入治疗后突发血小板减少症1例:“凶手”是肝素还是替罗非班? 被引量：8

下载PDF

导出

摘要 1临床资料患者男性58岁，因“上腹部不适，背痛1天”于2013年6月25日入院，患者在急诊心电图提示：Ⅱ、Ⅲ、aVF导联ST段抬高，I、aVL、V2～V6导联ST改变；超敏肌钙蛋白T：3.720 ng/ml。既往有高血压病史、胃窦炎病史、吸烟史40年。否认血小板减少性疾病病史。入院后予以强化抗凝抗血小板治疗：阿司匹林300 mg、氯吡格雷300 mg、低分子肝素6150 iu、替罗非班6 ml/h泵入。入院第二天行冠脉造影提示左冠状动脉前降支（LAD）近段90%狭窄，回旋支（LCX）中远段完全闭塞，于LCX置入支架。

作者曹天庆徐亚伟

机构地区上海市第十人民医院心内科

出处《中国循证心血管医学杂志》 2014年第3期364-365,共2页 Chinese Journal of Evidence-Based Cardiovascular Medicine

关键词低分子肝素替罗非班血小板减少症急性心肌梗死介入治疗后血小板减少性疾病高血压病史冠状动脉前降支

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献9

1无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690. 被引量：1974
2栾秀姝,李立环.肝素诱导的血小板减少症[J].中国体外循环杂志,2003,1(2):119-121. 被引量：18
3Warkentin TE,Kehon JG. Temporal aspects of heparin-induced thrombocylopenio[J]. N Engl J Med,2001,344( 17): 1286-92.
4Lubenow N,Kempf R,Eichner A,et al. Heparin-induced pattern of thrombocytopenia in relation to initial use or reexposure to heparin[J]. CHEST,2002,122(1):37-42.
5Greinacher A,Farner B, Kroll H,et al. Clinical features of heparin- induced thromboeytopenia including risk factors for thrombosis[J]. Thromb Haemost,2005,94(1): 132-5.
6Warkentin TE,Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T' s score[J]. J Thromb Haemost,2010,8(7):1483-5.
7Warkentin TE,Sheppard JA, Moore JC,et al. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need[J]? J Lab Clin Med,2005,146(6):341-6.
8赵永强.肝素诱导的血小板减少症诊断与治疗常见问题[J].中国实用内科杂志,2013,33(5):366-368. 被引量：32
9Huxtabte LM,Tafreshi MJ,Rakkar ANS. Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists[J]. The American journal of cardiology,2006,97(3):426-9.

二级参考文献23

1[1]James L. Januzzi Jr, et al. Fundamental Concepts in the Pathobiology of Heparin-induced Thrombocytopenia[J]. Journal of Thrombosis and Thrombolysis,2000;S7-11.
2[2]Jeanine M. Walenga, et al. Mechanisms of Venous and Arterial Thrombosis in Heparin-induced Thrombocytopenia[J]. Journal of Thrombosis and Thrombolysis,2000;S13-20.
3[3]Frederick A. Spencer, et al. Heparin-induced Thrombocytopenia:Patient Profiles and Clinical Manifestations[J]. Journal of Thrombosis and Thrombolysis,2000;S21-25.
4[4]Omar Ali. Images in Heparin-induced Thrombocytopenia[J]. Journal of Thrombosis and Thrombolysis,2000;S27-33.
5[5]Theodore E. Warkentin. Laboratory Testing for Pathobiology of Heparin-induced Thrombocytopenia[J]. Journal of Thrombosis and Thrombolysis,2000;S35-45.
6[6]Norbert Lubenow, et al.Management of Patient With Pathobiology of Heparin-induced Thrombocytopenia:Focus On Recombinant Hirudin[J]. Journal of Thrombosis and Thrombolysis,2000;S47-57.
7[7]Yves Gruel. Antiphospholipid Syndrome and Heparin-induced Thrombocytopenia: Update On Similarities and differences[J]. Journal of Autoimmunity,2000; 15:265-8.
8[8]P. A. Arndt, et al. Post-transfusion Purpura vs. Heparin-induced Thrombocytopenia: Differential Diagnosis in Clinical Practice[J]. Transfusion Medicine,2000;10:323-5.
9[9]Norbert Lubenow, et al. Very Low Platelet Counts in Post-transfusion Purpura Falsely Diagnosed as Heparin-induced Thrombocytopenia: report of four cases and review of literature[J]. Thrombosis Research,2000;100;115-125.
10[10]Ismail Elalamy, et al. Heparin-induced Thrombocytopenia: Laboratory Diagnosis and Management[J]. The Finnish Medical Society Duodecim, Ann Med,2000; 32 S1:60-67.